Imprimis Sanctioned Again For Flouting Discovery Order
A California federal judge has sanctioned Imprimis Pharmaceuticals Inc. for the second time after it violated a discovery order in a closely watched false advertising suit brought by Allergan USA Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article